Oxcarbazepine Tablet, Film Coated
Product Images NDC 55154-2138
Product Visual Gallery
This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Oxcarbazepine (NDC 55154-2138). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Cardinal Health 107, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Figure 1: Kaplan-meier Estimates Of Exit Rate By Treatment Group (Figure1)
Figure 2: Kaplan-meier Estimates Of First Seizure Event Rate By Treatment Group (Figure2)
Figure 3: Kaplan-meier Estimates Of Exit Rate By Treatment Group (Figure3)
Figure 4: Kaplan-meier Estimates Of Exit Rate By Treatment Group (Figure4)
150mg Bag Label (55a5fa71 3602 3e11 E063 6294a90a35a2 01)
300mg Bag Label (55a5fa71 3602 3e11 E063 6294a90a35a2 00)
* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.